TO

Takako Okumura

AS Askat: 11 patents #1 of 21Top 5%
RP Raqualia Pharma: 2 patents #23 of 69Top 35%
📍 Ebeye: #369 of 4,528 inventorsTop 9%
Overall (All Time): #373,560 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
11840530 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Shinichi Koizumi, Kazuhiko Nonomura 2023-12-12
10973834 EP4 inhibitors and use thereof Mark C. Manfredi, Jeffrey A. Ecsedy, Atsushi Nagahisa, Yukinori Take 2021-04-13
10947235 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Shinichi Koizumi, Kazuhiko Nonomura 2021-03-16
10786490 Use of EP4 receptor antagonists in the treatment of cartilage disease 2020-09-29
10611761 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Shinichi Koizumi, Kazuhiko Nonomura 2020-04-07
10583129 Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer Naoko Ohtani, Fumitaka KAMACHI, Tze Mun Loo, Shinichi Koizumi 2020-03-10
10391086 Use of EP4 receptor antagonists in the treatment of cartilage disease 2019-08-27
10342785 Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer Naoko Ohtani, Fumitaka KAMACHI, Tze Mun Loo, Shinichi Koizumi 2019-07-09
9688674 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Shinichi Koizumi, Kazuhiko Nonomura 2017-06-27
9561210 Therapeutic agent for ocular disease Shinichi Koizumi, Hideaki Hara 2017-02-07
9457084 Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseases Kiyoshi Kanazawa, Kazuhiko Nonomura, Shinichi Koizumi 2016-10-04
9447066 Salts and crystal forms Yoshiyuki Okumura, Yasuhiro Iwata, Toyoharu Numata, Masaki Sudo 2016-09-20
8921391 Selective EP4 receptor antagonistic substance for treatment of cancer Yukinori Take, Shinichi Koizumi, Kazuhiko Nonomura 2014-12-30